iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
Superinvestors holding IBIO, Q2 2026
No superinvestor reported holding IBIO in Q2 2026.